ResearchMoz

Leishmaniasis (Kala-Azar) Global Clinical Trials Review, Q1, 2011

Publisher Name » GlobalData
Published Date » 2011-01-31
No. Of Pages » 42

GlobalData's clinical trial report, Leishmaniasis (Kala-Azar) Global Clinical Trials Review, Q1, 2011" provides data on the Leishmaniasis (Kala-Azar) clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Leishmaniasis (Kala-Azar). It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Leishmaniasis (Kala-Azar)). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status and trial success rate
  • Review of key discontinued trials (suspended, withdrawn and terminated)
  • Overview of the enrollment pattern by phase for the past decade
  • Number of clinical trials segmented by key drugs
  • Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
  • Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy

  • Understand the dynamics of a particular indication as a whole
  • Examine the performance of the trials in terms of their status, recruitment, success rates and others
  • Obtain discontinued trial information for trials across the globe
  • Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Leishmaniasis (Kala-Azar) 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Subjects Recruited Over a Period of Time 19
Prominent Sponsors 20
Top Companies Participating in Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials 21
Prominent Drug Comparison 22
Clinical Trial Profiles 23
Clinical Trial Overview of Top Companies 23
Allermed Laboratories, Inc. 23
Clinical Trial Overview of Allermed Laboratories, Inc. 23
Paladin Labs Inc. 24
Clinical Trial Overview of Paladin Labs Inc. 24
GlaxoSmithKline plc 25
Clinical Trial Overview of GlaxoSmithKline plc 25
Clinical Trial Overview of Top Universities / Institutes / Hospitals 26
Banaras Hindu University 26
Clinical Trial Overview of Banaras Hindu University 26
Infectious Disease Research Institute 27
Clinical Trial Overview of Infectious Disease Research Institute 27
Drugs for Neglected Diseases initiative 28
Clinical Trial Overview of Drugs for Neglected Diseases initiative 28
Yale University 29
Clinical Trial Overview of Yale University 29
AB foundation 30
Clinical Trial Overview of AB foundation 30
University of Brasilia 31
Clinical Trial Overview of University of Brasilia 31
Hadassah Medical Organization 32
Clinical Trial Overview of Hadassah Medical Organization 32
U.S. Army Medical Materiel Development Activity 33
Clinical Trial Overview of U.S. Army Medical Materiel Development Activity 33
The National Institute of Allergy and Infectious Diseases 34
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 34
Hospital Universitrio Professor Edgard Santos 35
Clinical Trial Overview of Hospital Universitrio Professor Edgard Santos 35
Combined Military Hospital 36
Clinical Trial Overview of Combined Military Hospital 36
iOWH 37
Clinical Trial Overview of iOWH 37
University of California, San Francisco 38
Clinical Trial Overview of University of California, San Francisco 38

Appendix 39
Abbreviations 39
Definitions 39
Research Methodology 40
Secondary Research 40
About GlobalData 41
Contact Us 41
Disclaimer 41
Source 41

List of Tables


Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 9
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Asia-Pacific ,Top Countries, 2011* 10
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Europe, Top Countries, 2011* 11
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, North America, Top Countries, 2011* 12
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2011* 13
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2011* 14
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, BRIC Countries, 2011* 15
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Phase, 2011* 16
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 17
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 20
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 21
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 22
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Allermed Laboratories, Inc., 2011* 23
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Paladin Labs Inc., 2011* 24
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2011* 25
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Banaras Hindu University, 2011* 26
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Infectious Disease Research Institute, 2011* 27
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Drugs for Neglected Diseases initiative, 2011* 28
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2011* 29
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by AB foundation, 2011* 30
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Brasilia, 2011* 31
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2011* 32
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Army Medical Materiel Development Activity, 2011* 33
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2011* 34
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospital Universitrio Professor Edgard Santos, 2011* 35
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by Combined Military Hospital, 2011* 36
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by iOWH, 2011* 37
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011* 38

List of Figures


Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials in Progress by Top Countries, 2011* 9
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2011* 10
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2011* 13
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2011* 14
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, BRIC Countries (%), 2011* 15
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 16
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 17
Leishmaniasis (Kala-Azar) Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 18
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 19
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 20
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 21
Leishmaniasis (Kala-Azar) Therapeutics Clinical Trials, Global, Clinical Trial by Prominent Drugs, 2011* 22
GlobalData Methodology 40

Upcoming Reports:

Bakelite Market - Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2012 - 2018
By - Transparency Market Research
As one of the first plastics made from synthetic components, bakelite marks the start of plastics. Due to its electrical non-conductivity and heat resistant property, bakelite is majorly used for wire insulation, semi conductors, brake pads and related automotive components, and in industrial electrical-related applications. The commercial uses of bakelite are mainly in the manufacture of inexpensive games, billiard balls, and dominoes produced in countries like China, India, and Hong Kong due to its durability, fine finishing, weight, and sound. Bakelite has proven...
Mexico Ophthalmic Devices Market: Industry Size, Market Share, Trends,Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
SCOPE OF THE REPORT This report is an effort to identify factors, which will be the driving force behind the ophthalmic devices market and sub-markets in the next six years. This report is specially designed to estimate and analyze the demand and performance of Mexican ophthalmic devices market. The report provides extensive analysis of the ophthalmic devices industry, current market trends, industry drivers and challenges for better understanding of the ophthalmic devices market structure. The report has segregated the ophthalmic devices industry in terms of...
Signal Generators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2012 - 2018
By - Transparency Market Research
A signal generator is an electronic device that generates electronic signals of known oscillating voltages to test electronic instruments. Some of the factors driving the growth of this market are increasing demand for signal generators with greater precision, advanced features, and functionality of electronic devices.   Signal generators are usually used for troubleshooting and of electronic or electroacoustic devices. Electronic instrument makers with strong system capabilities are in better position to provide such equipments integrated with advanced features and...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.com
Select License type:

Share this report

Related News

One-third of Massachusetts Hospitals Facing Financial Downturn
Sep 14, 2012  
The healthcare Industry in the United States works as a separate entity and many of the healthcare services are privately owned and operated. Healthcare has always been a topic of debate for the U.S. government because policy makers argue that the system is not delivering value for money services. In fact government is spending twice as much on life expectancy and infant mortality rate...
Now At-Home TB Diagnosis Looks Possible
Sep 14, 2012  
According to a recent research published in Nature Chemistry, scientists have revealed that a certain sensitive fluorescent molecule is capable of efficiently and quickly tracing TB (tuberculosis) bacteria from the sputum samples. The year 2010 registered approximately 4000 deaths per day because of TB. TB diagnosis takes a few weeks and the disease being contagious puts others at...
China Economy Gets USD 157 Billion Stimulus with Sanction for 60 Infrastructure Projects
Sep 14, 2012  
Seen as a much required economical stimulus to revive the economy stuck in the worst slowdown in the past three years, China has approved 60 different infrastructure projects valued at more than USD 150 billion. Immediately after the official confirmation of the decision, stocks of major industries such as cement and steel have seen a rise on hopes generated by plans to build ports, highways,...
Battling against flu, vaccination necessary for health workers
Sep 14, 2012  
To battle against flu this season, health officials have tightened their resolve to get more health care workers vaccinated. Flu is a disease that transfers from one to another. Keeping this in mind health officials want every worker in the health care department to get vaccinated. By doing this, it will lessen the chances of others getting affected by this disease. Health officials...
Japan to Cut Import Duties on Indian Generic Drugs Imports
Sep 14, 2012  
The 44th ASEAN Economic Ministers Meeting held last week in Cambodia has certainly brought good news for the Indian Pharmaceuticals industry. During the meeting on the sidelines of the 44th ASEAN Economic Ministers Meet, Indian Commerce and Industry Minister Anand Sharma brought up the issue with his Japanese counterpart Yukio Edano. Yukio Edano is the minister of economy, trade and Industry...